Dr. William Audeh, MD, Chief Medical Officer, Agendia, presents, “The MINDACT Trial and the 70-gene MammaPrint assay: Long Term Follow-Up Data in HER+ Breast Cancer”. And, Dr. Lee Schwartzberg, MD, Chef Medical Officer, OneOncolog, presents, “Molecular Subtyping in Neoadjuvant Treatment.”

Posted on August 5, 2020
19 views